|Bid||1.8100 x 4000|
|Ask||1.8400 x 4000|
|Day's Range||1.8100 - 1.8550|
|52 Week Range||1.2200 - 5.3300|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||4.99|
|Earnings Date||Nov 05, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.70|
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.Below is a list of notable value stocks in the healthcare sector: 1. Ocugen (NASDAQ: OCGN) - P/E: 0.1 2. Lexicon Pharmaceuticals (NASDAQ: LXRX) - P/E: 5.94 3. Hepion Pharmaceuticals (NASDAQ: HEPA) - P/E: 3.95 4. Global Cord Blood (NYSE: CO) - P/E: 6.85 5. Five Star Senior Living (NASDAQ: FVE) - P/E: 3.5Ocugen saw a decrease in earnings per share from 0.89 in Q4 to -0.07 now. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Lexicon Pharmaceuticals has reported Q2 earnings per share at -0.65, which has decreased by 3.17% compared to Q1, which was -0.63. Lexicon Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.This quarter, Hepion Pharmaceuticals experienced a decrease in earnings per share, which was -0.92 in Q4 and is now -0.97. Hepion Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Global Cord Blood has reported Q4 earnings per share at 0.11, which has decreased by 35.29% compared to Q3, which was 0.17. Global Cord Blood does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.Five Star Senior Living has reported Q2 earnings per share at 0.1, which has increased by 118.18% compared to Q1, which was -0.55. Five Star Senior Living does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.See more from Benzinga * Overview Of Value Stocks In The Real Estate Sector * Analyzing Delta Air Lines's Unusual Options Activity * Analyzing Carnival's Unusual Options Activity(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
GTCR, a leading private equity firm, announced today that its TerSera Therapeutics LLC ("TerSera") portfolio company has entered into a definitive agreement to acquire the product Xermelo® (telotristat ethyl) from Lexicon Pharmaceuticals, Inc. ("Lexicon"; NASDAQ:LXRX) for an upfront purchase price of approximately $159 million plus potential milestone payments based on development and commercialization of Xermelo in a new indication.
One thing we could say about the analysts on Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) - they aren't optimistic...